Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

NCT00170833 ·Status: COMPLETED ·Phase: PHASE3

A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients

NCT00098007 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

NCT00150046 ·Status: COMPLETED ·Phase: PHASE3

A Study To Test An Anti-Rejection Therapy After Kidney Transplantation

NCT00000936 ·Status: TERMINATED ·Phase: PHASE3

Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

NCT00332839 ·Status: TERMINATED ·Phase: PHASE4

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

NCT00170885 ·Status: COMPLETED ·Phase: PHASE4

Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

NCT00241059 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients

NCT00443937 ·Status: COMPLETED ·Phase: PHASE4

Pediatric Kidney Transplant Without Calcineurin Inhibitors

NCT00023231 ·Status: COMPLETED ·Phase: NA

Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion

NCT00443508 ·Status: UNKNOWN ·Phase: PHASE4

Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients

NCT00239018 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

NCT00154297 ·Status: COMPLETED ·Phase: PHASE4

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

NCT00531063 ·Status: COMPLETED ·Phase: PHASE3

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

NCT00369161 ·Status: COMPLETED ·Phase: PHASE4

Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients

NCT00464399 ·Status: COMPLETED ·Phase: PHASE3

Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

NCT01517984 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

NCT05153915 ·Status: COMPLETED ·Phase: PHASE4

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

NCT00531440 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients

NCT01791491 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

NCT00251004 ·Status: COMPLETED ·Phase: PHASE3

Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation

NCT00903188 ·Status: UNKNOWN ·Phase: PHASE4

Rituximab for Pediatric Renal Transplant Rejection

NCT00697996 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

NCT00306397 ·Status: COMPLETED ·Phase: PHASE4

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

NCT00378014 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

NCT00820911 ·Status: COMPLETED ·Phase: PHASE2